Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma

NCT07064746 · clinicaltrials.gov ↗

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma (NB)

Interventions

DIAGNOSTIC_TEST: ¹²³I-MIBG SPECT/CT
DIAGNOSTIC_TEST: SSTR PET

Sponsor

Nanjing First Hospital, Nanjing Medical University

Collaborators

[object Object]